GemPharmatech is a global contract research organization that provides genetically engineered mouse models and preclinical research services to the scientific community. We have an extensive library of over 25,000 models including KO/cKO mice, humanized mice, immunodeficient mice, and germ-free mice, and continually expand our library to assist our customers in achieving their research goals. To further support our customers, we also offer custom model generation, breeding, and compound efficacy testing in our offices across China and the United States.

Cellecta Inc. is a trusted provider of genomic products and services for drug target and biomarker discovery. Since 2006, we have collaborated with the world’s leading pharma, biotech, government, and academic institutions. We apply our extensive expertise in viral vector production, functional screening, custom cell engineering and multiplex qRT-PCR to help researchers find the genes that matter.

Pixelgen is at the forefront of innovative life science research tools. Our technology, Molecular Pixelation (MPX), is used by our customers to enable spatial proteomics on single cells and gain new insights into cellular activity for applications such as drug development. The first product was launched in 2023 that targets the surface proteome of immune cells, thus enabling localization of 80 target proteins in 3D without the use of a microscope at high throughput and resolution. The MPX reagent kit is built on technology that forms DNA meshes and provides target identity, abundance and spatial location at the same time. The output is read on a sequencer and analyzed by our computational tools. Pixelgen was founded in 2020 by serial entrepreneurs behind multiple innovative products and companies in the life sciences and is located in Stockholm, Sweden. For more information, go to www.pixelgen.com.

Olink offers an unmatched high-multiplex technique to identify actionable biomarkers, with a strong focus on the human plasma proteome. Using minimal sample volume we provide quantifiable results with high-throughput, exceptional sensitivity and specificity, with coverage across a broad dynamic range. Our mission is to accelerate proteomics together with the scientific community across multiple disease areas to enable new discoveries and better understand complex real-time human biology. We are committed to develop our offering and are continuously expanding our protein coverage for a growing number of biological processes and pathways. Olink is well-established in Europe (HQ Uppsala, Sweden) and the USA (HQ Boston, MA), with a rapidly developing presence across Asia. We also work with a growing number of core labs around the world offering analysis and support to an expanding global customer base. For more information visit www.olink.com

SGS is the world’s leading inspection, verification, testing and certification company. With more than 90,000 employees, SGS operates a network of over 1,500 offices and laboratories around the world. The Life Science division serves pharmaceutical, biopharmaceutical, and medical device companies along the entire drug development pathway. With over 35 years’ experience as a global contract service organization, SGS provides integrated (bio)pharmaceutical development and testing solutions including clinical research, pharmaceutical development, biologics characterization, biosafety, and quality control testing for small and large molecules, raw materials, containers and finished products. SGS Vitrology provides a comprehensive range of biosafety services such as: virology, cell and molecular biology as well as microbiology and electron microscopy. Health Authorities, including the US FDA and the EMA, require companies to undergo safety testing demonstrating that cell banks, viral banks, raw materials, bulk harvests, and batches of clinical drug are free of bacteria, fungi, mycoplasma, viruses, and other potential contaminants. SGS Vitrology helps clients by ensuring product safety in satisfying these regulatory requirements. Our GLP/GMP facility is MHRA certified, and US FDA audited.

10x Genomics was founded on the vision that this century will bring advances in biomedicine and transform the way we understand and treat disease. We deliver powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Our end-to-end single cell and spatial solutions include instruments, consumables, and intuitive software, letting you unravel highly intricate biological systems, while bringing into focus the details that matter most.

ABL is a pure play Contract Development and Manufacturing Organization (CDMO) specialized in the development and manufacturing of virus for vaccine candidates, gene and cancer therapies. ABL's mission is to provide GMP viral vectors from early-stage to market, contributing to the success of their clients' innovations. ABL's CDMO services offer a one-stop-shop and end-to-end CMC including bulk drug substance, fill/finish of drug products, process and assay development, as well as regulatory support. ABL has a unique experience with a broad range of viral vectors including poxvirus, arenavirus, lentivirus and adeno associated virus (AAV). ABL is a subsidiary of the Institut Mérieux Group and operates from various locations in Europe and the US.

About Batavia Biosciences Batavia Biosciences significantly contributes to ease human suffering from infectious diseases and cancer by leveraging our innovative technologies and in-depth know-how at all stages of the development trajectory, from the transition into early clinical studies, to navigating late stage clinical development and entering commercial manufacturing at higher speed, reduced costs, and with increased success. The company operates state-of-the-art development and manufacturing facilities in Europe and the US and, as part of the CJ CheilJedang global family, is building a strong position in global health with its strategic partners worldwide. For more information visit www.bataviabiosciences.com

Volition is at the forefront of epigenetic immunoassay development, contributing to the drug discovery and development cycle from in-vitro target validation to human clinical trials. Esteemed collaborators and customers utilize our technology in oncology and immunotherapy applications. Our primary objective is to deliver actionable insights that streamline drug development processes, from early-stage discovery to clinical trials. Nu.Q® Discover assays have been validated in preclinical PD studies tracking epigenetic modification levels in response to epigenetic inhibitors with recent data presented at AACR demonstrating a dose-dependent reduction in specific Histone PTM levels by simple liquid biopsy. We have developed an assay for NETosis, quantifying the release of Neutrophil Extracellular Traps. This assay is being used to assess innate immune response in acute inflammatory conditions, including sepsis resulting from infectious disease and cancer. Our Ex-vivo – Synthetic Sepsis™ platform is designed to screen NETosis modulators and potential activators, providing ex-vivo human data ahead of First-in-Human (FIH) studies. Adhering to rigorous industry standards, our assays are available as RUO kits, with select assays, such as Nu.Q®- NETS, CE-marked for clinical use. For specialized requirements, we can develop new assays following CLSI development guidelines. Our R&D activities are anchored in Belgium, complemented by an innovation lab in California and offices in Texas, London, and Singapore. For more details and scientific data please visit, volition.com.

GemPharmatech Co., Ltd. specializes in generating genetically engineered mouse models (GEMMs) and providing trusted preclinical services to our customers. Our team of scientists has extensive experience creating animal models using cutting edge gene-editing technologies. Their expertise and commitment to animal model development has resulted in GemPharmatech having one of the world's largest collections of knockout and conditional knockout mice, known as our Knockout All Project (KOAP). We also have an impressive collection of humanized, immunodeficient, and disease models. Our goal is to provide our customers with the best resources to accelerate biomedical discovery and drug development.

Nanion Technologies is a global leading life sciences tools company combining since more than 20 years exceptional instrumentation with trusted scientific support, to accelerate successful drug development and scientific discoveries. As a leading provider of automated patch clamp systems with a wide range of throughput capabilities and formats, we have expanded our product range to in vitro systems for membrane pump/transporter, bilayer recordings, contractility and cell analytics measurements. From studying the biophysical properties and pharmacological profile of ion channels and transporters in native and reconstituted membranes to understanding the effect of their modulation on cell survival and function, our state-of-the-art instrumentation has revolutionized drug discovery, lead optimisation and safety assessment. Here we launch the last product from Nanion Technologies, AtlaZ instrument for high-throughput impedance spectroscopy measurements, allowing simultaneous, label-free and time resolved monitoring of diverse cellular responses. With the capability to track live cells in a 6x 96-well plate configuration, AtlaZ operates across a range of frequencies (0.1 KHz – 100 KHz), unveiling nuanced information about cell confluence, providing insights into proliferation and cytotoxicity, as well as formation of tight junction in epithelial and endothelial cell lines. Easy to set-up and use, AtlaZ is provided with an easy-to-use user interface providing real-time and automated data analysis. Applications include: Cell Proliferation, Cytotoxicity, Immune Cell-Mediated Cytotoxicity, Cancer Immunotherapy, Immuno-Oncology, Receptor-mediated Signalling.

Sino Biological is an international reagent supplier and service provider. The company specializes in recombinant protein production and antibody development. All of Sino Biological's products are independently developed and produced, including recombinant proteins, antibodies and cDNA clones. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements. In addition, Sino Biological offers pharmaceutical companies and biotechnology firms pre-clinical production technology services for hundreds of monoclonal antibody drug candidates.

Standard BioTools™, previously known as Fluidigm®, is driven by a bold vision – Unleashing tools to accelerate breakthroughs in human health. Standard BioTools provides an established portfolio of essential, standardized technologies that empower customers to scale and accelerate their life sciences research. From interrogating cell function and cancer-immune cell interactions to confidently determining new biomarkers or integrity of samples, Standard BioTools promotes the development of breakthrough medicines faster and better through the delivery of consistent, reliable and repeatable results.

Ultivue provides researchers and scientists in translational medicine with multiplex biomarker assays and spatial image analysis for tissue phenotyping and digital pathology. Its proprietary InSituPlex® technology enables advanced exploration and interrogation of tissue samples for precision medicine research. These highly customizable solutions coupled with our scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs.